Expert Perspectives on Managing AF: Update on the Essentials


CME: 2.00

Add to my calendar

Activity Description:

Topics covered in this program included:

  • Anticoagulation and stroke prevention (including new devices and cardioversion)
  • Heart failure in AF
  • Appropriate selection and endpoints for antiarrhythmic drug therapy
  • Patient selection and techniques surrounding catheter ablation to cure AF


Civista Medical Center
La Plata, MD USA

Course Directors/Faculty:

Cynthia M. Tracy, MD
George Washington University Medical Center

Jeffrey Trabb, MD
Chesapeake & Washington Heart Care, PC

Learning Objectives:

  • Demonstrate awareness of the existence of the CHADS2 risk index for assessment of stroke risk in patients with nonvalvular atrial fibrillation
  • Calculate a CHADS2 risk score for assessment of stroke risk in patients with nonvalvular atrial fibrillation
  • Employ CHADS2 results in making management decisions for patients with nonvalvular atrial fibrillation
  • Associate patients with algorithm categories for Maintenance of Sinus Rhythm
  • Select appropriate pharmacotherapy (including antiarrhythmic therapy) for patients with AF characterized by minimal to no heart disease; hypertension with substantial LVH; hypertension without substantial LVH; CAD
  • Refer patients to EPs for consultation when appropriate
  • Identify appropriate anticoagulation strategies prior to and following cardioversion
  • Provide anticoagulation therapy for the appropriate period before and after cardioversion

Accreditation Statement:

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Disclosure Statement:

It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational programs. Everyone involved in the planning and participation of continuing medical education activities are required to disclose any real or apparent conflict of interest related to the content of their presentations and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The Heart Rhythm Society implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Detailed disclosure information will be disclosed prior to the activity and in the activity slides.

Contact Information:

Greaton Sellers
Tel: 202-464-3400

CME/CE Certificate Language:

The Heart Rhythm Society designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the USA who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.